Strides Pharma Science Limited has informed the Exchange regarding Change in Director(s) of the company.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science announced board and management changes effective June 1, 2026. Ram (Venkata Seetharama Raju Pakalapati), currently COO with 18 years at Strides, has been elevated to Executive Director and KMP, moving from SMP to board level. Aditya Arun Kumar, currently Executive Director - Business Development, is stepping down from his executive role and being redesignated as Non-Executive Director (Non-Independent). Aditya, who is the son of Founder and Chairperson Arun Kumar and part of the Promoter Group, cited the promoters' intention to further professionalize management as the reason for his transition. Nandini Matiyani (Executive VP HR) and Ariff Khan (Executive VP Manufacturing Operations) have been newly nominated as SMPs. The May 20 filing corrected a typographical error in an earlier announcement.
The promotion of an internal leader (Ram) to the board and the professionalization move by the promoter family member (Aditya) represent governance changes that may signal management succession planning and increased professional oversight. Shareholders should note the changes in KMP composition.